Oncology Products in the European Union: An Analysis of Regulatory Approvals with a CHMP Oral Explanation
Crossref DOI link: https://doi.org/10.1007/s43441-021-00303-x
Published Online: 2021-05-26
Published Print: 2021-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Oger, Alexandra http://orcid.org/0000-0001-5219-1898
Torqui, Aimad
Kester, Robert
Wissink, Sacha
Text and Data Mining valid from 2021-05-26
Version of Record valid from 2021-05-26
Article History
Received: 29 January 2021
Accepted: 5 May 2021
First Online: 26 May 2021
Declarations
:
: There are no competing interests to declare.